Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Palisade Bio (PALI) FCF Margin (2016 - 2023)

Palisade Bio has reported FCF Margin over the past 11 years, most recently at 1410.4% for Q1 2023.

  • Quarterly FCF Margin changed N/A to 1410.4% in Q1 2023 from the year-ago period, while the trailing twelve-month figure was 4453.2% through Dec 2023, changed N/A year-over-year, with the annual reading at 4454.8% for FY2023, N/A changed from the prior year.
  • FCF Margin was 1410.4% for Q1 2023 at Palisade Bio, up from 61960.0% in the prior quarter.
  • Over five years, FCF Margin peaked at 1410.4% in Q1 2023 and troughed at 81957.28% in Q4 2019.
  • The 3-year median for FCF Margin is 34720.0% (2020), against an average of 44244.09%.
  • Year-over-year, FCF Margin plummeted -1982152bps in 2019 and then surged 4116960bps in 2020.
  • A 3-year view of FCF Margin shows it stood at 81957.28% in 2019, then increased by 24bps to 61960.0% in 2020, then skyrocketed by 98bps to 1410.4% in 2023.
  • Per Business Quant, the three most recent readings for PALI's FCF Margin are 1410.4% (Q1 2023), 61960.0% (Q4 2020), and 34720.0% (Q3 2020).